Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Musicki B, Bella AJ, Bivalacqua TJ, Davies KP, DiSanto ME, Gonzalez-Cadavid NF, Hannan JL, Kim NN, Podlasek CA, Wingard CJ, Burnett AL.

J Sex Med. 2015 Dec;12(12):2233-55. doi: 10.1111/jsm.13069. Epub 2015 Dec 8. Review.


The role of the urologist in the prevention and early detection of cardiovascular disease.

Yassin AA, Saad F, Haider A, Gooren L.

Arab J Urol. 2011 Mar;9(1):57-62. doi: 10.1016/j.aju.2011.03.014. Epub 2011 May 6. Review.


The treatment of late-onset hypogonadism.

Üçer O, Gümüş B.

Turk J Urol. 2014 Sep;40(3):170-9. doi: 10.5152/tud.2013.97752. Epub 2014 Mar 24. Review.


Chronic kidney disease and erectile dysfunction.

Suzuki E, Nishimatsu H, Oba S, Takahashi M, Homma Y.

World J Nephrol. 2014 Nov 6;3(4):220-9. doi: 10.5527/wjn.v3.i4.220. Review.


Secondary infertility and the aging male, overview.

Katib AA, Al-Hawsawi K, Motair W, Bawa AM.

Cent European J Urol. 2014;67(2):184-8. doi: 10.5173/ceju.2014.02.art13. Epub 2014 Jun 23. Review.


Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.

Gareri P, Castagna A, Francomano D, Cerminara G, De Fazio P.

Int J Endocrinol. 2014;2014:878670. doi: 10.1155/2014/878670. Epub 2014 Mar 17. Review.


Total testosterone levels and the effect of sildenafil on type 2 diabetics with erectile dysfunction.

Hadeed NN, Thanoon IA, Al-Mukhtar SB.

Oman Med J. 2014 Jan;29(1):46-50. doi: 10.5001/omj.2014.10.


Treatment Strategy for Non-Responders to PDE5 Inhibitors.

Park NC, Kim TN, Park HJ.

World J Mens Health. 2013 Apr;31(1):31-5. doi: 10.5534/wjmh.2013.31.1.31. Epub 2013 Apr 23.


Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review.

Alhathal N, Elshal AM, Carrier S.

Can Urol Assoc J. 2012 Aug;6(4):269-74. doi: 10.5489/cuaj.11291.


Testosterone, endothelial health, and erectile function.

Castela A, Vendeira P, Costa C.

ISRN Endocrinol. 2011;2011:839149. doi: 10.5402/2011/839149. Epub 2011 Sep 6.


Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism.

Kim JW, Moon du G.

Korean J Urol. 2011 Nov;52(11):725-35. doi: 10.4111/kju.2011.52.11.725. Epub 2011 Nov 17.


Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axis.

Tomada I, Tomada N, Almeida H, Neves D.

Age (Dordr). 2013 Feb;35(1):35-47. doi: 10.1007/s11357-011-9328-z. Epub 2011 Nov 4.


Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Aversa A, Bruzziches R, Francomano D, Natali M, Lenzi A.

Ther Adv Urol. 2009 Oct;1(4):179-97. doi: 10.1177/1756287209344992.


Onset of effects of testosterone treatment and time span until maximum effects are achieved.

Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L.

Eur J Endocrinol. 2011 Nov;165(5):675-85. doi: 10.1530/EJE-11-0221. Epub 2011 Jul 13. Review.


Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.

Ko YH, Kim JJ.

Asian J Androl. 2011 Jul;13(4):563-8. doi: 10.1038/aja.2010.124. Epub 2011 May 16. Review.


Combination therapy for erectile dysfunction: an update review.

Dhir RR, Lin HC, Canfield SE, Wang R.

Asian J Androl. 2011 May;13(3):382-90. doi: 10.1038/aja.2011.2. Epub 2011 Mar 21. Review.


Androgens and male aging: Current evidence of safety and efficacy.

Gooren LJ.

Asian J Androl. 2010 Mar;12(2):136-51. doi: 10.1038/aja.2010.4. Epub 2010 Feb 15. Review.


Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Sadovsky R, Brock GB, Gutkin SW, Sorsaburu S.

Int J Clin Pract. 2009 Aug;63(8):1214-30. doi: 10.1111/j.1742-1241.2009.02119.x. Review.


Erectile dysfunction in a murine model of sleep apnea.

Soukhova-O'Hare GK, Shah ZA, Lei Z, Nozdrachev AD, Rao CV, Gozal D.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):644-50. doi: 10.1164/rccm.200801-190OC. Epub 2008 Jun 5.


Testosterone for the aging male; current evidence and recommended practice.

Stanworth RD, Jones TH.

Clin Interv Aging. 2008;3(1):25-44. Review.

Items per page

Supplemental Content

Write to the Help Desk